Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prevention of COVID-19 Caused by SARS-CoV-2”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Testing effectiveness (Phase 2)Study completedNCT04712110
What this trial is testing

TAK-019 in Healthy Japanese Adults (COVID-19)

Who this might be right for
Prevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
Takeda 200
Not applicableEnded earlyNCT05084755
What this trial is testing

VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Subjects With Underlying Disease at High-risk for Worsening COVID-19

Who this might be right for
Prevention of Infectious Disease Caused by SARS-CoV-2
AstraZeneca 4
Not applicableStudy completedNCT04681001
What this trial is testing

Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers

Who this might be right for
Respiratory Viral InfectionCommon ColdSevere Acute Respiratory Syndrome (SARS) Pneumonia+2 more
Marinomed Biotech AG 300
Not applicableStudy completedNCT05687877
What this trial is testing

Evusheld Japan PMS_Japan Post-Marketing Surveillance (PMS)

Who this might be right for
SARS-CoV-2 Infection
AstraZeneca 366
Large-scale testing (Phase 3)UnknownNCT06068569
What this trial is testing

Study of the Vector Vaccine GamCovidVac for the Prevention of COVID-19 With Altered Antigenic Profile With Participation of Adult Volunteers

Who this might be right for
COVID-19
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 50
Testing effectiveness (Phase 2)UnknownNCT04713488
What this trial is testing

An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine

Who this might be right for
COVID-19 Prevention
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 110
Testing effectiveness (Phase 2)UnknownNCT05248373
What this trial is testing

Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal Spray

Who this might be right for
COVID-19SARS-CoV-2 Acute Respiratory Disease
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 400
Very early researchUnknownNCT05679466
What this trial is testing

An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older

Who this might be right for
Prevention of COVID-19 Caused by SARS-CoV-2
Yu Qin 3,300
Not applicableStudy completedNCT04894409
What this trial is testing

Evaluation of Silver Nanoparticles for the Prevention of COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Cluster de Bioeconomia de Baja California, A.C 231
Large-scale testing (Phase 3)UnknownNCT04954092
What this trial is testing

Study of Gam-COVID-Vac in Adolescents

Who this might be right for
Covid19Vaccine Preventable Disease
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 3,000
Not applicableStudy completedNCT05135455
What this trial is testing

VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Long-term Safety of VAXZEVRIA

Who this might be right for
Prevention of Infectious Disease Caused by SARS-CoV-2
AstraZeneca 467
Early research (Phase 1)WithdrawnNCT04590274
What this trial is testing

Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Who this might be right for
Covid19SARS (Severe Acute Respiratory Syndrome)
International Brain Research Foundation
Testing effectiveness (Phase 2)Study completedNCT04590547
What this trial is testing

GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)

Who this might be right for
PneumonitisSARS-CoV Infection
GeneOne Life Science, Inc. 132
Large-scale testing (Phase 3)UnknownNCT06057025
What this trial is testing

Study of "Sputnik Lite" for the Prevention of COVID-19 With Altered Antigenic Composition.

Who this might be right for
COVID-19
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 50
Large-scale testing (Phase 3)UnknownNCT06068556
What this trial is testing

Study of the Vector Vaccine GamCovidVac-M (Altered Antigenic Composition)

Who this might be right for
COVID-19
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 50
Testing effectiveness (Phase 2)UnknownNCT04760821
What this trial is testing

Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for COVID-19

Who this might be right for
Acute Respiratory Distress SyndromeCovid19Myocardial Injury
Ministry of Health, Brazil 80
Large-scale testing (Phase 3)Study completedNCT04973449
What this trial is testing

Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults

Who this might be right for
COVID-19SARS-CoV-2
AstraZeneca 2,843